Ansell Healthcare Awarded Product Line Award
REDBANK, NJ-Frost and Sullivan have awarded Ansell Healthcare, Inc., the 2000 Market Engineering Award for Product Line Strategy.
Ansell Healthcare is a manufacturer of barrier protective products. The company has been recognized for its ability to optimize their product line by leveraging products with various price, performance, and feature points.
Each year, Frost and Sullivan recognize an outstanding industry achievement by presenting marketing engineering awards to top companies in a variety of regional and global markets. The Market Engineering Award for Product Line Strategy is awarded to companies who demonstrate the most insight into customer need and demand. The criteria used to determine the recipient include: introduction of new products, strategically positioned to balance the product line; ability to accommodate different market segments, or different markets within an industry, finding different purposes for a technology; enhancement of product offerings through optimization of packaging, service, delivery, financing and/or other value-added services; and strategic technology or marketing acquisitions or alliances.
For more information visit www.ansell.com
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
The Critical Role of Rapid Diagnostics in Antibiotic Stewardship
November 6th 2024Rapid diagnostics enhance patient outcomes by enabling prompt, targeted treatments, reducing inappropriate antibiotic use, and combating antimicrobial resistance through informed clinical decisions and stewardship programs.
